Xolair.com

Xolair.com has Server used 52.52.174.250 IP Address with Hostname in United States. Below listing website ranking, Similar Webs, Backlinks. This domain was first 1999-12-08 (21 years, 192 days) and hosted in San Jose United States, server ping response time 164 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Xolair keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Xolair
2 Xolair injections
3 Xolair injections cost
4 Xolair application form
5 Xolair goodrx
6 Xolair syringe
7 Xolaircopay com
8 Xolair cost
9 Xolair side effects

Hosting Provider

Website: Xolair.com
Hostname: ec2-52-52-174-250.us-west-1.compute.amazonaws.com
Country:
Region: CA
City: San Jose
Postal Code: 95141
Latitude: 37.339401245117
Longitude: -121.89499664307
Area Code: 408
Email AbuseNo Emails Found

Find Other Domains on Any IP/ Domain


New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   » Jashore.org (4 seconds ago)

   » Hotubthing.com (2 seconds ago)

   » Nijjareyecare.com (6 seconds ago)

   » Abbeyhousedental.com (12 seconds ago)

   » Toancap3.com (34 seconds ago)

   » Ndcl.org (10 seconds ago)

   » Uta.org (0 seconds ago)

   » Cashforcarscalifornia.com (16 seconds ago)

   » Loughboora.com (3 seconds ago)

   » Buycials.com (15 seconds ago)

Results For Websites Listing

Found 48 Websites with content related to this domain, It is result after search with search engine

XOLAIR® (Omalizumab) For Allergic Asthma, Nasal Polyps

Xolair.com   DA: 14 PA: 14 MOZ Rank: 28

  • XOLAIR ® (omalizumab) for subcutaneous use is an injectable prescription medicine used to treat: moderate to severe persistent asthma in people 6 years of age and older whose asthma symptoms are not well controlled with asthma medicines called inhaled corticosteroids
  • A skin or blood test is performed to see if you have allergies to year-round

Xolair: Side Effects, Dosage & Uses

Drugs.com   DA: 13 PA: 12 MOZ Rank: 26

  • What is Xolair? Xolair (omalizumab) is an antibody that helps decrease allergic responses in the body
  • Xolair is used to treat moderate to severe asthma that is caused by allergies in adults and children who are at least 6 years old
  • Xolair is used when asthma symptoms are not controlled by asthma inhaled steroid medicine.

Allergic Asthma Treatment

Xolairhcp.com   DA: 17 PA: 21 MOZ Rank: 40

XOLAIR ® (omalizumab) is indicated for: Adults and pediatric patients 6 years of age and older with moderate to severe persistent asthma who have a positive skin test or in vitro reactivity to a perennial aeroallergen and whose symptoms are inadequately controlled with inhaled corticosteroids.

Xolair Subcutaneous: Uses, Side Effects, Interactions

Webmd.com   DA: 13 PA: 47 MOZ Rank: 63

  • Omalizumab is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma that is due to year-round allergens
  • Controlling symptoms of asthma helps you

Xolair: Side Effects, Cost, Uses, And More

Medicalnewstoday.com   DA: 24 PA: 16 MOZ Rank: 44

  • Xolair is a brand-name prescription drug that’s used to treat certain forms of allergic asthma and chronic hives
  • Learn about side effects, warnings, dosage, and more.

XOLAIR® (omalizumab) Dosing For Allergic Asthma, CIU

Xolairhcp.com   DA: 17 PA: 31 MOZ Rank: 53

  • XOLAIR prefilled syringe should be shipped and stored under refrigerated conditions 2°C to 8°C (36°F to 46°F) in the original carton
  • XOLAIR vial should be shipped at a controlled ambient temperature (≤30°C [≤86°F]) and stored under refrigerated conditions (2°C to …

XOLAIR Access Solutions XOLAIR® (omalizumab) For

Genentech-access.com   DA: 24 PA: 23 MOZ Rank: 53

Learn about XOLAIR Access Solutions, a resource that provides reliable, effective access and reimbursement support to assist your patients and practice after XOLAIR® (omalizumab) for subcutaneous use has been prescribed.

XOLAIR Co-pay Program

Xolaircopay.com   DA: 19 PA: 19 MOZ Rank: 45

XOLAIR ® (omalizumab) for subcutaneous use is an injectable prescription medicine used to treat: moderate to severe persistent asthma in people 6 years of age and older whose asthma symptoms are not well controlled with asthma medicines called inhaled corticosteroids.

Omalizumab (marketed As Xolair) Information FDA

Fda.gov   DA: 11 PA: 50 MOZ Rank: 69

Xolair is an injectable medicine for patients 12 years of age and older with moderate to severe persistent allergic asthma whose asthma symptoms are not controlled by asthma medicines called

XOLAIR Forms & Documents XOLAIR Access Solutions

Genentech-access.com   DA: 24 PA: 43 MOZ Rank: 76

  • XOLAIR Access Solutions Enrollment Forms
  • To download multiple files at once, select the checkbox next to each file you would like to download from the list above then click Download Selected
  • Documents will be downloaded as a .zip file.

FDA Warns About Asthma Drug, Xolair

Webmd.com   DA: 13 PA: 50 MOZ Rank: 73

  • Xolair was the first biologic, or biotechnology product, developed to treat such allergy-related asthma when it was brought to the market in 2003.
  • At the time of the FDA review, Xolair

Omalizumab (Xolair) Uses, Side Effects & Dosage

Medicinenet.com   DA: 19 PA: 23 MOZ Rank: 53

  • Omalizumab (Xolair) is a drug prescribed for the treatment of asthma that is not adequately controlled with inhaled steroids
  • Side effects, drug interactions, and patient warnings should be reviewed prior to taking this medication.

Xolair™ (Omalizumab)

Aapc.com   DA: 12 PA: 50 MOZ Rank: 74

  • Xolair™ is a medical benefit and should be administered in the physician’s office
  • After the initial medical criteria for coverage is met for Xolair™, additional treatment with Xolair™ will be covered as long as the patient has a positive response to treatment.

Xolair® (omalizumab)

Specialtydrug.magellanprovider.com   DA: 34 PA: 36 MOZ Rank: 83

  • Xolair 75 mg single-dose prefilled syringe: 1 syringe every 14 days Xolair 150 mg single-dose prefilled syringe: 2 syringes every 14 days Xolair 150mg powder for injection: 3 vials every 14 days B
  • Max Units (per dose and over time) [Medical Benefit]: Allergic Asthma …

Xolair Side Effects Cancer, Vasculitis & Other Risks

Drugwatch.com   DA: 17 PA: 21 MOZ Rank: 52

  • Xolair is an injectable treatment for allergy-related illnesses, including moderate to severe allergic asthma and chronic hives that cannot be traced to a known cause
  • It is given once or twice a month by a physician or other medical professional in a health care setting
  • Users may experience a range of common side effects, including pain isolated at joints, arms and legs or spread out across

HIGHLIGHTS OF PRESCRIBING INFORMATION Measured …

Gene.com   DA: 12 PA: 36 MOZ Rank: 63

  • XOLAIR is not indicated for the relief of acute bronchospasm or status asthmaticus
  • XOLAIR is not indicated for treatment of other allergic conditions
  • 1.2 Nasal Polyps XOLAIR is indicated for add-on maintenance treatment of nasal polyps in adult patients 18 years of age and older with inadequate response to nasal corticosteroids.

XOLAIR® Omalizumab For Subcutaneous Use DESCRIPTION

Accessdata.fda.gov   DA: 22 PA: 47 MOZ Rank: 85

  • XOLAIR® Omalizumab For Subcutaneous Use DESCRIPTION Xolair (Omalizumab) is a recombinant DNA-derived humanized IgG1κ monoclonal antibody that selectively binds to human immunoglobulin E (IgE)
  • The antibody has a molecular weight of approximately 149 kilodaltons

Xolair (Omalizumab) Drug / Medicine Information

News-medical.net   DA: 20 PA: 18 MOZ Rank: 55

  • Xolair contains omalizumab, a monoclonal antibody produced by recombinant DNA technology
  • It works by blocking a substance produced by the body called immunoglobulin E (or IgE)

Xolair® (Omalizumab) – Commercial Medical Benefit Drug …

Uhcprovider.com   DA: 19 PA: 50 MOZ Rank: 87

  • Xolair (omalizumab) for subcutaneous use is proven for patients with chronic urticaria who continue to remain symptomatic despite H1 antihistamine [e.g., cetirizine (Zyrtec), fexofenadine (Allegra)] treatment
  • Xolair is medically necessary when all of the following criteria are met: Diagnosis of chronic urticaria; and One of the following:

Xolair Cost (Omalizumab)

Prescriptionhope.com   DA: 20 PA: 19 MOZ Rank: 58

  • Xolair is mainly used to treat the symptoms of allergic asthma and chronic hives
  • Xolair is a subcutaneous injectable medication
  • This medication may also be given with other treatments for these conditions.Xolair is given as one or more injections once every 2 to 4 weeks.

Xolair 150mg Injection: View Uses, Side Effects, Price And

1mg.com   DA: 11 PA: 36 MOZ Rank: 67

  • Xolair 150mg Injection is a monoclonal antibody
  • It is used in the treatment of moderate to severe asthma in both adults and children
  • It eases the symptoms of asthma such as wheezing, breathlessness, tightness in your chest, and coughing
  • Xolair 150mg Injection is given as an injection under the supervision of a doctor.

Xolair® (Omalizumab) – Oxford Clinical Policy

Uhcprovider.com   DA: 19 PA: 50 MOZ Rank: 90

Xolair is medically necessary when all of the following criteria are met: Diagnosis of moderate or severe asthma; and Classification of asthma as uncontrolled or inadequately controlled as defined by at least one of the following: o Poor symptom control (e.g., Asthma Control Questionnaire [ACQ] score consistently greater than 1.5 or Asthma

Xolair European Medicines Agency

Ema.europa.eu   DA: 17 PA: 31 MOZ Rank: 70

  • The active substance in Xolair, omalizumab, is a monoclonal antibody, a type of protein, designed to attach to IgE, which is produced in large quantities in patients with allergies and triggers an allergic reaction in response to an allergen
  • By attaching to IgE, omalizumab ‘mops up’ the free IgE in the blood
  • This means that when the body encounters an allergen, there is less IgE

To Compare The PK And Safety Of Omalizumab(CT-P39, EU

Clinicaltrials.gov   DA: 22 PA: 21 MOZ Rank: 66

  • To Compare the PK and Safety of Omalizumab(CT-P39, EU-approved Xolair, and US-licensed Xolair) in Healthy Subjects
  • The safety and scientific validity of this study is the responsibility of the study sponsor and investigators
  • Listing a study does not mean it has been evaluated by the U.S

Reference ID: 3955374

Accessdata.fda.gov   DA: 22 PA: 46 MOZ Rank: 92

  • Xolair is not indicated for treatment of other forms of urticaria
  • 2 DOSAGE AND ADMINISTRATION 2.1 Dosage for Asthma Administer Xolair 75 to 375 mg by subcutaneous injection every 2 or 4 weeks
  • Determine dose (mg) and dosing frequency by serum total IgE level (IU/mL) measured before the start

Xolair Prices, Coupons & Savings Tips

Goodrx.com   DA: 14 PA: 7 MOZ Rank: 46

  • About GoodRx Prices and Xolair Coupons
  • GoodRx‘s cash prices are based on multiple sources, including published price lists, purchases, claims records, and data provided by pharmacies
  • Our discount and coupon prices are based on contracts between a pharmacy (or pharmacy purchasing group) and a Pharmacy Benefit Manager (PBM), who

FDA Approves Xolair (omalizumab) Prefilled Syringe For

Businesswire.com   DA: 20 PA: 50 MOZ Rank: 96

After Xolair therapy has been initiated and safely established in a healthcare setting, a healthcare provider may determine whether self-injection with Xolair prefilled syringe by …

Novartis Receives Positive CHMP Opinion For New Xolair

Novartis.com   DA: 16 PA: 50 MOZ Rank: 93

  • Xolair (omalizumab) is the only approved anti-immunoglobulin E (IgE) antibody treatment specifically designed to target and block IgE
  • By reducing free IgE, down-regulating high-affinity IgE receptors and limiting mast cell degranulation, Xolair minimizes the release of mediators throughout the allergic inflammatory cascade.

Novartis' Xolair® Recommended In New Global Chronic

Novartis.com   DA: 16 PA: 50 MOZ Rank: 94

  • Xolair is the only licensed treatment option for CSU, a type of CU, for patients unresponsive to antihistamines[1]
  • CU, including CSU, is a severe disease that causes itchy, persistent hives and painful swelling
  • The guideline recommends Xolair as the only treatment qualified with very good efficacy and very good safety in CSU[2].

Xolair CMI Of 31.05.02 Submitted

Medsafe.govt.nz   DA: 19 PA: 27 MOZ Rank: 75

  • Xolair is only available with a doctor's prescription
  • You should not receive Xolair if you have an allergy to: • omalizumab (the active ingredient in Xolair) or any of the other ingredients listed at the end of this leaflet
  • Symptoms of an allergic reaction may

Xolair Lawsuit Lawyer

Levinlaw.com   DA: 16 PA: 50 MOZ Rank: 96

  • What Are The Most Serious Side-Effects of Xolair
  • The most serious side effects from Xolair is an increased risk of severe cardiovascular and cerebrovascular issues, and also anaphylaxis (a serious allergic reaction that can cause the throat to swell, blocking the air passage).

Xolair Medicare Coverage And Co-Pay Details

Goodrx.com   DA: 14 PA: 25 MOZ Rank: 70

  • After your deductible has been satisfied, you will enter the Post-Deductible (also called Initial Coverage) stage, where you pay your copay and your plan covers the rest of the drug cost
  • In the Donut Hole (also called the Coverage Gap) stage, there is a temporary limit to what Medicare

Recently Analyzed Sites

Jashore.org (4 seconds ago)

Hotubthing.com (2 seconds ago)

Drtomtrevisani.com (0 seconds ago)

Abbeyhousedental.com (12 seconds ago)

Toancap3.com (34 seconds ago)

Ndcl.org (10 seconds ago)

Uta.org (0 seconds ago)

Cashforcarscalifornia.com (16 seconds ago)

Loughboora.com (3 seconds ago)

Buycials.com (15 seconds ago)

Carenetnc.org (22 seconds ago)

Suekenfisher.com (4 seconds ago)

Suffolkanimalrescue.org (0 seconds ago)

Microknack.com (3 seconds ago)

Xolair.com (0 seconds ago)

Sudlisboa.com (16 seconds ago)

1818kc.com (7 seconds ago)

Chockfastorange.com (0 seconds ago)